This site is intended for health professionals only

Published on 6 July 2007

Share this story:

RELATED ARTICLES
Semaglutide beneficial in patients with type 2 diabetes and obesity-related heart failure
No evidence of causal link between GLP-1 receptor agonists and suicide, says PRAC
In conversation with consultant pharmacist in cardiology Dr Rani Khatib
Simple treatment strategies could reduce high risk of myocardial infarction in kidney failure
New study challenges aspirin guidelines for patients at risk of atherosclerotic cardiovascular disease

Rosuvastatin freed from black triangle

teaser

Following a comprehensive analysis of pre- and postmarketing data by the UK’s MHRA and Commission on Human Medicines, the risk-benefit profile for rosuvastatin (Crestor



Most read

1
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
2
Oral vitamin A could become an alternative to isotretinoin for acne
3
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
5
Launch of the new Hospital Pharmacy Europe Mobile App



Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
Share this story:

RELATED ARTICLES
Paediatric lung transplantation
Diabetes: sugar moderation needed
Arranging planned care in hospitals and diagnostic services: NICE guideline summary
Viramune® approved in EU for HIV-1 treatment
Sharps Directive: influencing pharmacy and procurement

Download Hospital Pharmacy Europe free app

Download our app from the Apple App Store Download our app from Google Play

© Cogora 2024
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x